Breast Cancer Liquid Biopsy Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Breast Cancer Liquid Biopsy Market size is expected to grow at an annual average of 22% during 2021-2027. Breast cancer liquid biopsy is a non-invasive alternative technique that uses blood as a sample and is the preferred choice over surgical tissue biopsy. There are various biomarkers used as tools for the detection of breast cancer, such as circulating tumor cells (CTCs), extracellular vesicles, and circulating tumor DNA. Breast cancer liquid biopsy helps monitor the progression of breast cancer disease based on the heterogeneity of tumor cells in the advanced stages of breast cancer. Breast cancer liquid biopsy tests also detect epidermal growth factor receptor (EGFR) gene mutations that help clinicians choose the right breast cancer treatment at the right time.

The following segmentation are covered in this report:

By Application

• Diagnostics
• Prognostics
• Risk assessment

By Product Services

• Reagent Kits
• Instruments
• Services

By Circulating Biomarker

• Circulating Tumor Cells
• Extracellular Vesicles
• Circulating Tumor DNA

Company Profile

• BIOCEPT INC.
• F. HOFFMANN-LA ROCHE LTD. (FOUNDATION MEDICINE, INC.)
• FLUXION BIOSCIENCES, INC.
• MENARINI GROUP (MENARINI SILICON BIOSYSTEMS, INC.)
• MYRIAD GENETICS, INC.
• NEOGENOMICS LABORATORIES, INC.
• QIAGEN N.V.
• SYSMEX CORPORATION
• THERMO FISHER SCIENTIFIC, INC.
• GUARDANT HEALTH, INC.

Scope of the report

The research study analyses the Breast Cancer Liquid Biopsy Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Breast Cancer Liquid Biopsy Market Report

• What was the Breast Cancer Liquid Biopsy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Breast Cancer Liquid Biopsy Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.